# HARMONY BIOSCIENCES HLDGS IN (HRMY)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/HRMY/

- Reporting holders: 8
- Reported value: $1.1M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [ARGENT CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/1120926-argent-capital-management-llc/) | $646.5K | 16,468 | 0.0% | 1 |
| [City Center Advisors, LLC](https://holderbook.com/funds/2030341-city-center-advisors-llc/) | $360.5K | 9,182 | 0.3% | 5 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $32.0K | 816 | 0.0% | 13 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $27.2K | 693 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $14.3K | 364 | 0.0% | 18 |
| [CX Institutional](https://holderbook.com/funds/1737089-cx-institutional/) | $8.6K | 217,882 | 0.2% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $6.2K | 159 | 0.0% | 7 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $158 | 4 | 0.0% | 2 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $79 | 2 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 8 | $1.1M |
| Q2 2026 | 330 | $2.1B |
| Q1 2026 | 313 | $1.6B |
| Q4 2025 | 327 | $1.9B |
| Q3 2025 | 301 | $1.4B |
| Q2 2025 | 282 | $1.6B |
| Q1 2025 | 273 | $1.7B |
| Q4 2024 | 247 | $1.8B |
| Q3 2024 | 235 | $2.0B |
| Q2 2024 | 220 | $1.5B |
| Q1 2024 | 211 | $1.7B |
| Q4 2023 | 222 | $1.6B |

